Wako Distributing Cellectis Products in Japan | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French genomic engineering firm Cellectis said on Wednesday it has appointed Wako Pure Chemical Industries as its exclusive distributor in Japan.

Wako will handle sales of Cellectis' products including its Talen Access service, launched in February. In a statement, Luc Selig, vice president of sales and marketing for Cellectis, said that the company is targeting global distribution of Talen, which is a tool for specifically modifying genes in any type of cell.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.